EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preoperative Systemic Inflammatory Indices (SII, SIRI and PIV) Associated with Adverse Histology and 12-Month Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

Dragoș Florin Vasile iD, Mihnea Meșină, George G Mitroi, Alexandru-Daniel Danilă, Cosmin Vasile Obleaga, Mihai Alexandru Radu iD, Georgică Târtea, George F Mitroi

Journal of Clinical Medicine · 02.11.2026 · 15 (21) · 8536

DOI: 10.3390/jcm15218536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.11.2026. Verfasst von Dragoș Florin Vasile und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Non-muscle-invasive bladder cancer (NMIBC) recurs frequently, and clinicopathological tools predict recurrence imperfectly. We assessed whether six preoperative blood-count-derived inflammatory indices (SII, SIRI, PIV, NLR, PLR, and LMR) are associated with adverse histology and 12-month recurrence and whether SIRI adds prognostic information to established risk factors.

Methods

We retrospectively analysed 180 consecutive NMIBC patients treated by transurethral resection of bladder tumour (TURBT) and immediate instillation. Indices were modelled per 1-SD in logistic (adverse histology: high grade, T1 or carcinoma in situ) and Cox (recurrence) models adjusted for established risk factors.

Results

Adverse histology occurred in 121 patients (67.2%); 88 recurred (12-month Kaplan–Meier estimate: 49.2%). All six indices were univariably associated with both endpoints, with similar effects (SIRI: adverse histology OR: 2.35, 95% CI: 1.41–3.90; recurrence HR: 1.41, 1.19–1.67). After adjustment, SIRI was not independently associated with adverse histology (OR: 1.69, 0.92–3.11) or recurrence (HR: 1.10, 0.86–1.40) and did not improve discrimination (ΔC: 0.001, −0.006 to 0.016). Results were robust across sensitivity analyses, including propensity weighting for BCG (limited by positivity violations).

Conclusions

SIRI added no demonstrable independent prognostic value. Given modest overfitting (optimism-corrected calibration slope: 0.79), neither the indices nor the model should be used clinically without external validation and recalibration.

Schlagwörter

Stichwörter der Autor:innen

TURBTnon-muscle-invasive bladder cancerpan-immune–inflammation valuerecurrencesystemic immune–inflammation indexsystemic inflammation response index

Autor:innen und Institutionen

  • Department of Urology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania.
  • Department of Dermatology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania.
  • Department of Urology, County Emergency Hospital of Târgu-Jiu, 18 Progresului Street, 210218 Târgu-Jiu, Romania.
  • Department of Surgical Oncology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania.
  • Experimental Research Centre for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania.
  • Department of Cardiology, University of Medicine and Pharmacy of Craiova, 2 Petru Rareș Street, 200349 Craiova, Romania.

ORCID-Profile: Dragoș Florin Vasile, Mihai Alexandru Radu

Zitieren

APA

Vasile, D. F., Meșină, M., Mitroi, G. G., Danilă, A. D., Obleaga, C. V., Radu, M. A., Târtea, G., & Mitroi, G. F. (2026). Preoperative Systemic Inflammatory Indices (SII, SIRI and PIV) Associated with Adverse Histology and 12-Month Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer. Journal of Clinical Medicine, 15(21), 8536. https://doi.org/10.3390/jcm15218536

Vancouver

Vasile DF, Meșină M, Mitroi GG, Danilă AD, Obleaga CV, Radu MA, et al. Preoperative Systemic Inflammatory Indices (SII, SIRI and PIV) Associated with Adverse Histology and 12-Month Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer. Journal of Clinical Medicine. 2026;15(21):8536. doi:10.3390/jcm15218536

BibTeX
@article{Vasile2026,
  author = {Vasile, Dragoș Florin and Meșină, Mihnea and Mitroi, George G and Danilă, Alexandru-Daniel and Obleaga, Cosmin Vasile and Radu, Mihai Alexandru and Târtea, Georgică and Mitroi, George F},
  title = {Preoperative Systemic Inflammatory Indices (SII, SIRI and PIV) Associated with Adverse Histology and 12-Month Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {21},
  pages = {8536},
  doi = {10.3390/jcm15218536}
}
Kostenlos starten →